Company / Capital Expenditures
CLOVER HEALTH INVESTMENTS, CORP. /DE Capital Expenditures History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$2.0M
FY2025
5-year range
$584.0K / $4.5M
FY2021-FY2025
Trend
+31.3%
vs FY2024
Sector context
#140 of 150
Health Care
What the data says
Among 150 Health Care companies, CLOVER HEALTH INVESTMENTS, CORP. /DE is in the bottom 7% for capital expenditures. Improved from $584,000 to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of +24.1%.
Improved from $584,000 to $2M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -23.0%
- 5-Year CAGR
- +24.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 150This company $2.0M Sector average $271.1M
▼
-99.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +24.1%, indicating consistent growth.
- In FY2025, capital expenditures increased 31.3% year-over-year.
- Ranks #140 out of 150 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.0M | +31.3% |
| FY2024 | $1.6M | +166.4% |
| FY2023 | $584.0K | -86.9% |
| FY2022 | $4.5M | +517.8% |
| FY2021 | $723.0K | +4.3% |
| FY2020 | $693.0K | +2913.0% |
| FY2019 | $23.0K | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026